Guru Ownership Trend
Guru Analysis for Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $134.73 M.
Top institutional holders include Steven Cohen and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $47.26 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Celldex Therapeutics, Inc. (CLDX)
Major holders include Steven Cohen ($102.45 M), Ken Fisher ($32.15 M), Paul Tudor Jones ($1.12 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 4.29 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $47.26 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited CLDX. The total reported sell value was $3.22 M.
Yes, 2 managers opened new positions in CLDX, and 2 increased their existing holdings. The total reported buy value was $50.47 M.